Center for Scientific Review; Notice of Closed Meetings, 52480-52481 [2015-21396]
Download as PDF
<![CDATA[
tkelley on DSK3SPTVN1PROD with NOTICES
52480
Federal Register / Vol. 80, No. 168 / Monday, August 31, 2015 / Notices
experimental data to support the
experimental hypothesis. Specifically:
1. ORI found falsified and/or
fabricated data in Paper 1 in:
a. Figure 5B by manipulation of the
HER3 protein concentrations in the
experiment to provide the desired
outcome
b. Figure 6C for the identification of the
kinase domain construct EGFR–
V924R by falsely claiming that both
EGFR and HER3 contained the kinase
domains and the full JM segments,
when the JM–HER3 construct
included cloning tags
c. Figure 6D by manually manipulating
the error bars to increase statistical
significance of the kinase assay
2. ORI found falsified and/or
fabricated data in Paper 2 in:
a. Figure 3C by manually altering some
of the data points by 10–20% support
the desired hypothesis
b. Figure 4A by manipulating data
points and reducing error bars and
failing to report that JM–HER3
construct had cloning tags
c. Figure 4B by reducing several data
points by ∼ 15%
Mr. Littlefield has entered into a
Voluntary Settlement Agreement and
has voluntarily agreed:
(1) To have his research supervised
for period of three (3) years beginning
on August 4, 2015; Respondent agreed
that prior to the submission of an
application for U.S. Public Health
Service (PHS) support for a research
project on which his participation is
proposed and prior to his participation
in any capacity on PHS-supported
research, Respondent shall ensure that a
plan for supervision of his duties is
submitted to ORI for approval; the
supervision plan must be designed to
ensure the scientific integrity of his
research contribution; Respondent
agreed that he will not participate in
any PHS-supported research until such
a supervision plan is submitted to and
approved by ORI; Respondent agreed to
maintain responsibility for compliance
with the agreed upon supervision plan;
(2) that for period of three (3) years
beginning on August 4, 2015, any
institution employing him shall submit
in conjunction with each application for
PHS funds, or report, manuscript, or
abstract involving PHS-supported
research in which Respondent is
involved, a certification to ORI that the
data provided by Respondent are based
on actual experiments or are otherwise
legitimately derived, and that the data,
procedures, and methodology are
accurately reported in the application,
report, manuscript, or abstract;
VerDate Sep<11>2014
16:19 Aug 28, 2015
Jkt 235001
(3) to exclude himself voluntarily
from serving in any advisory capacity to
PHS including, but not limited to,
service on any PHS advisory committee,
board, and/or peer review committee, or
as a consultant for period of three (3)
years beginning on August 4, 2015; and
(4) to retraction or correction of the
following papers:
• Science Signaling 7:ra114, 2014
• Chemistry & Biology 21:453–458,
2014
FOR FURTHER INFORMATION CONTACT:
Acting Director, Office of Research
Integrity, 1101 Wootton Parkway, Suite
750, Rockville, MD 20852, (240) 453–
8200.
Scientific Review Program; Division of
Extramural Activities, Room 3F52B; National
Institutes of Health/NIAID; 5601 Fishers
Lane, MSC 9823; Bethesda, MD 20892–9823;
(240) 669–5044; nv19q@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: August 26, 2015.
David Clary,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–21481 Filed 8–28–15; 8:45 am]
BILLING CODE 4140–01–P
Donald Wright,
Acting Director, Office of Research Integrity.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2015–21421 Filed 8–28–15; 8:45 am]
National Institutes of Health
BILLING CODE 4150–31–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; NIAID Investigator Initiated
Program Project Applications (P01).
Date: September 25 and 28, 2015.
Time: September 25, 2015, 12:30 p.m. to
4:30 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health; Room
3F52B; 5601 Fishers Lane; Rockville, MD
20892; (Telephone Conference Call).
Time: September 28, 2015, 9:30 a.m. to
2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health; Room
3F52B; 5601 Fishers Lane; Rockville, MD
20892; (Telephone Conference Call).
Contact Person: Nancy VazquezMaldonado, Ph.D., Scientific Review Officer;
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR Panel:
Pregnancy in Women with Disabilities.
Date: September 21, 2015.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Telephone Conference Call).
Contact Person: Delia Olufokunbi Sam,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158,
MSC 7770, Bethesda, MD 20892, 301–435–
0684, olufokunbisamd@csr.nih.gov.
Name of Committee: Emerging
Technologies and Training Neurosciences
Integrated Review Group, Bioengineering of
Neuroscience, Vision and Low Vision
Technologies Study Section.
Date: September 29, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: St. Gregory Luxury Hotel & Suites,
2033 M Street NW., Washington, DC 20036.
Contact Person: Robert C Elliott, Ph.D.,
Scientific Review Officer, Center for
E:\FR\FM\31AUN1.SGM
31AUN1
Federal Register / Vol. 80, No. 168 / Monday, August 31, 2015 / Notices
tkelley on DSK3SPTVN1PROD with NOTICES
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5190,
MSC 7846, Bethesda, MD 20892, 301–435–
3009, elliotro@csr.nih.gov.
Name of Committee: Emerging
Technologies and Training Neurosciences
Integrated Review Group, Molecular
Neurogenetics Study Section.
Date: October 1–2, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Garden Inn Bethesda, 7301
Waverly Street, Bethesda, MD 20814.
Contact Person: Eugene Carstea, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194,
MSC 7846, Bethesda, MD 20892, (301) 408–
9756, carsteae@csr.nih.gov.
Name of Committee: Risk, Prevention and
Health Behavior Integrated Review Group,
Addiction Risks and Mechanisms Study
Section.
Date: October 1–2, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: JW Marriott New Orleans, 614 Canal
Street, New Orleans, LA 70130.
Contact Person: Kristen Prentice, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112,
MSC 7808, Bethesda, MD 20892, (301) 496–
0726, prenticekj@mail.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group, Biomedical
Imaging Technology B Study Section.
Date: October 5–6, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Mark Center,
5000 Seminary Road, Alexandria, VA 22311.
Contact Person: Lee Rosen, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5116,
MSC 7854, Bethesda, MD 20892, (301) 435–
1171, rosenl@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: August 25, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2015–21396 Filed 8–28–15; 8:45 am]
BILLING CODE 4140–01–P
VerDate Sep<11>2014
16:19 Aug 28, 2015
Jkt 235001
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is
hereby given of the following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Cell Biology
Integrated Review Group; Nuclear and
Cytoplasmic Structure/Function and
Dynamics Study Section.
Date: September 28–29, 2015.
Time: 8:00 a.m. to 12:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hotel Palomar; 2121 P Street NW.;
Washington, DC 20037.
Contact Person: David Balasundaram,
Ph.D.; Scientific Review Officer; Center for
Scientific Review; National Institutes of
Health; 6701 Rockledge Drive, Room 5189,
MSC 7840; Bethesda, MD 20892; 301–435–
1022; balasundaramd@csr.nih.gov.
Name of Committee: Oncology 2—
Translational Clinical Integrated Review
Group; Drug Discovery and Molecular
Pharmacology Study Section.
Date: October 1–2, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Renaissance Arts Hotel; 700
Tchoupitoulas Street; New Orleans, LA
70130.
Contact Person: Jeffrey Smiley, Ph.D.;
Scientific Review Officer; Center for
Scientific Review; National Institutes of
Health; 6701 Rockledge Drive, Room 6194,
MSC 7804; Bethesda, MD 20892; 301–594–
7945; smileyja@csr.nih.gov.
Name of Committee: Surgical Sciences,
Biomedical Imaging and Bioengineering
Integrated Review Group; Medical Imaging
Study Section.
Date: October 5–6, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Hilton Alexandria Mark Center;
5000 Seminary Road; Alexandria, VA 22311.
Contact Person: Xiang-Ning Li, MD, Ph.D.;
Scientific Review Officer; Center for
Scientific Review; National Institutes of
Health; 6701 Rockledge Drive, Room 5112,
MSC 7854; Bethesda, MD 20892; 301–435–
1744; lixiang@csr.nih.gov.
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
52481
Name of Committee: Center for Scientific
Review Special Emphasis Panel; PAR13–137:
Bioengineering Research.
Date: October 6, 2015.
Time: 8:00 a.m. to 9:00 a.m.
Agenda: To review and evaluate grant
applications.
Place: Fairmont Washington DC; 2401 M
Street NW.; Washington, DC 20037.
Contact Person: Yvonne Bennett, Ph.D.;
Scientific Review Officer; Center for
Scientific Review; National Institutes of
Health; 6701 Rockledge Drive, Room 5199,
MSC 7846; Bethesda, MD 20892; 301–379–
3793; bennetty@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Pain and Chemosensory
Mechanisms.
Date: October 6–7, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health; 6701
Rockledge Drive; Bethesda, MD 20852;
(Virtual Meeting).
Contact Person: John Bishop, Ph.D.;
Scientific Review Officer; Center for
Scientific Review; National Institutes of
Health; 6701 Rockledge Drive, Room 5182,
MSC 7844; Bethesda, MD 20892; (301) 408–
9664; bishopj@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Alcohol, Neurotoxicology and
Drugs.
Date: October 6–7, 2015
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications
Place: National Institutes of Health; 6701
Rockledge Drive; Bethesda, MD 20892;
(Virtual Meeting).
Contact Person: Michael Selmanoff, Ph.D.;
Scientific Review Officer; Center for
Scientific Review; National Institutes of
Health; 6701 Rockledge Drive, Room 5164,
MSC 7844; Bethesda, MD 20892; 301–435–
1119; selmanom@csr.nih.gov.
Name of Committee: Emerging
Technologies and Training Neurosciences
Integrated Review Group; Neuroscience and
Ophthalmic Imaging Technologies Study
Section.
Date: October 6–7, 2015.
Time: 9:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: Fairmont Washington DC; 2401 M
Street NW.; Washington, DC 20037.
Contact Person: Yvonne Bennett, Ph.D.;
Scientific Review Officer; Center for
Scientific Review; National Institutes of
Health; 6701 Rockledge Drive, Room 5199,
MSC 7846; Bethesda, MD 20892; 301–379–
3793; bennetty@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Clinical and Visual Neurosciences.
Date: October 7, 2015.
Time: 11:00 a.m. to 2:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health; 6701
Rockledge Drive; Bethesda, MD 20892.
E:\FR\FM\31AUN1.SGM
31AUN1
]]>Agencies
[Federal Register Volume 80, Number 168 (Monday, August 31, 2015)]
[Notices]
[Pages 52480-52481]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2015-21396]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of Closed Meetings
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended (5 U.S.C. App.), notice is hereby given of the following
meetings.
The meetings will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: Center for Scientific Review Special Emphasis
Panel; PAR Panel: Pregnancy in Women with Disabilities.
Date: September 21, 2015.
Time: 2:00 p.m. to 4:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institutes of Health, 6701 Rockledge Drive,
Bethesda, MD 20892 (Telephone Conference Call).
Contact Person: Delia Olufokunbi Sam, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3158, MSC 7770, Bethesda, MD
20892, 301-435-0684, olufokunbisamd@csr.nih.gov.
Name of Committee: Emerging Technologies and Training
Neurosciences Integrated Review Group, Bioengineering of
Neuroscience, Vision and Low Vision Technologies Study Section.
Date: September 29, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: St. Gregory Luxury Hotel & Suites, 2033 M Street NW.,
Washington, DC 20036.
Contact Person: Robert C Elliott, Ph.D., Scientific Review
Officer, Center for
[[Page 52481]]
Scientific Review, National Institutes of Health, 6701 Rockledge
Drive, Room 5190, MSC 7846, Bethesda, MD 20892, 301-435-3009,
elliotro@csr.nih.gov.
Name of Committee: Emerging Technologies and Training
Neurosciences Integrated Review Group, Molecular Neurogenetics Study
Section.
Date: October 1-2, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Garden Inn Bethesda, 7301 Waverly Street,
Bethesda, MD 20814.
Contact Person: Eugene Carstea, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 5194, MSC 7846, Bethesda, MD
20892, (301) 408-9756, carsteae@csr.nih.gov.
Name of Committee: Risk, Prevention and Health Behavior
Integrated Review Group, Addiction Risks and Mechanisms Study
Section.
Date: October 1-2, 2015.
Time: 8:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant applications.
Place: JW Marriott New Orleans, 614 Canal Street, New Orleans,
LA 70130.
Contact Person: Kristen Prentice, Ph.D., Scientific Review
Officer, Center for Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3112, MSC 7808, Bethesda, MD
20892, (301) 496-0726, prenticekj@mail.nih.gov.
Name of Committee: Surgical Sciences, Biomedical Imaging and
Bioengineering Integrated Review Group, Biomedical Imaging
Technology B Study Section.
Date: October 5-6, 2015.
Time: 8:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: Hilton Alexandria Mark Center, 5000 Seminary Road,
Alexandria, VA 22311.
Contact Person: Lee Rosen, Ph.D., Scientific Review Officer,
Center for Scientific Review, National Institutes of Health, 6701
Rockledge Drive, Room 5116, MSC 7854, Bethesda, MD 20892, (301) 435-
1171, rosenl@csr.nih.gov.
(Catalogue of Federal Domestic Assistance Program Nos. 93.306,
Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893,
National Institutes of Health, HHS)
Dated: August 25, 2015.
Michelle Trout,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2015-21396 Filed 8-28-15; 8:45 am]
BILLING CODE 4140-01-P
